profit from every $100 of sales.

VSee Health
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
It has no yearly profit to compare the price with.
It holds more cash than debt.
Money in, money out
What VSee Health sold, what it kept, and what it did with the cash.
Sales went from $6.38 million in 2022 to $14.6 million in 2025, with -$14.7 million of profit last year.
VSee Health vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
VSee Health | No profit yet | ||
GE HealthCare Technologies | 17.9× · Fair price | ||
Tempus AI | No profit yet | ||
BrightSpring Health Services | 75.8× · Very expensive | ||
HealthEquity | 39.6× · Expensive |
AI analysis
An AI analyst reads VSee Health's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 6 | 6 | 10 | 15 | |
| 5 | 4 | 7 | 7 | |
| -1 | -2 | -5 | -10 | |
| -2 | -2 | -58 | -9 | |
| -1 | -4 | -58 | -15 | |
| -0.06 | -0.26 | – | -0.73 | |
| 75.8% | 66.5% | 68.9% | 50.3% | |
| -23.0% | -31.0% | -44.9% | -65.6% | |
| -13.1% | -65.3% | -553.7% | -100.6% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3 | 1 | 20 | 22 |
| Cash | 0 | 0 | 0 | 5 |
| Total debt | 1 | 1 | 10 | 3 |
| Total liabilities | 3 | 5 | 20 | 17 |
| 0 | -4 | -0 | 5 | |
| 15 | 15 | – | 20 | |
| -142.9% | – | -490.2% | -107.3% | |
| -231.8% | 94.7% | 312,105.2% | -269.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -1 | -1 | -6 | -3 | |
| – | 0 | 0 | 0 | |
| -1 | -1 | -6 | -3 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | 0 | 1 | 1 |
Valuation
- –
- –
- –
- 0.7×
- 0.0×
- –
- –
- -479.1%
- -2,028.3%
- 0.0%
Profitability
- 50.3%
- -65.6%
- -100.6%
- -62.8%
- -119.7%
- -155.4%
- 629.0%
- -65.6%
- -155.4%
- –
Growth
- +31.8%
- –
- +40.5%
- –
- +19.3%
Financial health
- -0.2×
- 0.45
- 10.9%
- -3.4×
- 0.51
- 0.51
- 0.65
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 15, 2026 | -0.05 | -0.11 | +54.5% |
| Mar 31, 2026 | -0.31 | -0.08 | −287.5% |
| Nov 14, 2025 | -0.02 | -0.08 | +75.0% |
| Oct 15, 2025 | -0.14 | -0.12 | −16.7% |
| Aug 28, 2025 | -0.36 | -0.09 | −295.1% |
| Nov 14, 2024 | -0.81 | – | – |
| Sep 23, 2024 | -0.06 | – | – |
| May 14, 2024 | -0.00 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about VSee Health
Is VSee Health a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the VSee Health AI analysis
What does VSee Health do?
VSee Health, Inc. provides telehealth care solutions. It is in Medical - Healthcare Information Services.
Does VSee Health pay a dividend?
No. VSee Health does not pay a dividend at the moment.
Is VSee Health stock halal?
No. VSee Health does not pass our halal screen: its debt is 449% of its market value, at or above the 33% limit. How we check
How has VSee Health stock done over the past year?
Up 5.9% over the past twelve months, to $0.90. It traded between $0.01 and $2.28 and is 60.5% below its high.
Who are VSee Health's competitors?
The largest listed companies in the same industry are GE HealthCare Technologies, Tempus AI, BrightSpring Health Services and HealthEquity. The peers table on this page compares their profit, growth and price with VSee Health's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.



